These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12191657)

  • 1. Recent advances in cryptosporidiosis: the immune response.
    Riggs MW
    Microbes Infect; 2002 Aug; 4(10):1067-80. PubMed ID: 12191657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
    Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
    Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum.
    Ehigiator HN; Romagnoli P; Priest JW; Secor WE; Mead JR
    Parasitol Res; 2007 Sep; 101(4):943-50. PubMed ID: 17487508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection.
    Liu K; Zai D; Zhang D; Wei Q; Han G; Gao H; Huang B
    Parasite Immunol; 2010 May; 32(5):335-44. PubMed ID: 20500662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate and cell-mediated immune responses to Cryptosporidium parvum.
    Theodos CM
    Adv Parasitol; 1998; 40():87-119. PubMed ID: 9554071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis.
    Schaefer DA; Auerbach-Dixon BA; Riggs MW
    Infect Immun; 2000 May; 68(5):2608-16. PubMed ID: 10768951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.
    Enriquez FJ; Riggs MW
    Infect Immun; 1998 Sep; 66(9):4469-73. PubMed ID: 9712802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempts to protect severe combined immunodeficient (scid) mice with antibody enriched for reactivity to Cryptosporidium parvum surface antigen-1.
    Tatalick LM; Perryman LE
    Vet Parasitol; 1995 Jul; 58(4):281-90. PubMed ID: 8533267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of recombinant P23 protein as a vaccine for passive immunization of newborn calves against Cryptosporidium parvum.
    Askari N; Shayan P; Mokhber-Dezfouli MR; Ebrahimzadeh E; Lotfollahzadeh S; Rostami A; Amininia N; Ragh MJ
    Parasite Immunol; 2016 May; 38(5):282-9. PubMed ID: 27012710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.
    Benitez A; Priest JW; Ehigiator HN; McNair N; Mead JR
    Vaccine; 2011 Nov; 29(49):9239-45. PubMed ID: 21968447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.
    Matsubayashi M; Teramoto-Kimata I; Uni S; Lillehoj HS; Matsuda H; Furuya M; Tani H; Sasai K
    J Biol Chem; 2013 Nov; 288(47):34111-34120. PubMed ID: 24085304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-based immunotherapy of cryptosporidiosis.
    Crabb JH
    Adv Parasitol; 1998; 40():121-49. PubMed ID: 9554072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.
    Doyle PS; Crabb J; Petersen C
    Infect Immun; 1993 Oct; 61(10):4079-84. PubMed ID: 8406795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.
    Perryman LE; Kapil SJ; Jones ML; Hunt EL
    Vaccine; 1999 Apr; 17(17):2142-9. PubMed ID: 10367947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of SA35 and SA40 peptides in mice enhances humoral and cellular immune responses and confers protection against Cryptosporidium parvum infection.
    Tosini F; Ludovisi A; Tonanzi D; Amati M; Cherchi S; Pozio E; Gómez-Morales MA
    Parasit Vectors; 2019 May; 12(1):233. PubMed ID: 31092283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immune responses in mice by a DNA vaccine encoding Cryptosporidium parvum Cp12 and Cp21 and its effect against homologous oocyst challenge.
    Yu Q; Li J; Zhang X; Gong P; Zhang G; Li S; Wang H
    Vet Parasitol; 2010 Aug; 172(1-2):1-7. PubMed ID: 20541869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen.
    Jenkins M; Kerr D; Fayer R; Wall R
    Vaccine; 1995 Dec; 13(17):1658-64. PubMed ID: 8719516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of T lymphocytes from previously infected calves to recombinant Cryptosporidium parvum P23 vaccine antigen.
    Wyatt CR; Lindahl S; Austin K; Kapil S; Branch J
    J Parasitol; 2005 Oct; 91(5):1239-42. PubMed ID: 16419781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterization of a 17-kDa antigen from Cryptosporidium parvum recognized early by mucosal IgA antibodies.
    Reperant JM; Naciri M; Chardes T; Bout DT
    FEMS Microbiol Lett; 1992 Nov; 78(1):7-14. PubMed ID: 1468619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.